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Total synthesis of the bicyclo[6.3.0]undecane-based sesquiterpene
(±)-asterisca-3(15),6-diene. Revision of the relative
stereochemistry of the natural product
Goverdhan Mehta* and Jayant D. Umarye
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, India
Abstract—The first total synthesis of the novel bicyclic sesquiterpene hydrocarbon asterisca-3(15),6-diene is reported. As a
consequence, the natural product is shown to possess structure 4 with a trans-5,8 ring fusion and not the previously assigned
cis-asterisca-3(15),6-diene 3.
In 1985, a novel 5,8-ring fused sesquiterpene aster-
iscanolide 1 was isolated from Asteriscus aquaticus L.
(family compositae).1a Subsequently, two new natural
products 3-hydroxy-6-asteriscene 21b and asterisca-
3(15),6-diene 31c from the essential oil of Lippia integri-
folia (Griseb) were added in 1995 and 1999,
respectively, to this rare bicyclo[6.3.0]undecane-based
family of sesquiterpenes. While the stereostructure of
asteriscanolide 1 was secured through a X-ray crystal
structure determination,1a those of 2 and 3 were largely
deduced from the analyses of their spectral data.1b,c
The absolute configuration of 2 and 3 remains
unknown. All the three asteriscanes 1–3 were formu-
lated as having a cis-fused 5,8-ring junction. Aster-
iscanolide 1, being the first member of this new skeletal
type among sesquiterpenes, has aroused considerable
synthetic interest2 and four total syntheses3a–d and sev-
eral synthetic approaches3e–g have been reported. How-
ever, synthetic endeavours towards 2 and 3 have not
been reported in the literature so far. We describe here
the first synthesis of the natural product asterisca-
3(15),6-diene and demonstrate that the stereostructure
of the naturally occurring hydrocarbon needs to be
revised to 4 with trans-ring fusion.
Our approach to the bicyclo[6.3.0]undecane system was
based on the ‘carbocyclic ring equivalency’ concept.4
Scheme 1.
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Thus, bicyclo[3.3.0]octane is an eight-membered ring
equivalent and tricyclo[6.3.0.02,6]undecane (linear
triquinane) is the latent form of the bicyclo-
[6.3.0]undecane system (Scheme 1). In the backdrop of
this theme, our synthesis of 3 (corresponding to the
previously assigned1c cis-fused formulation) emanated
from the cis,syn,cis-triquinane bis-enone 6, readily and
quantitatively available from the pentacyclic-caged
dione 5 through flash-vacuum pyrolysis (FVP) as
described by us many years ago.5 Relocation of one of
the enone moieties in 6 through thermal activation
under static conditions led to the bis-enone 7 (Scheme
2). Controlled, selective catalytic hydrogenation to 8
and regioselective gem-dimethylation delivered 9.6
Chemoselective thioketalisation in 9 gave monothioke-
tal 10, which was subjected to reductive desulfurisation
in metal–ammonia milieu to yield a diastereomeric mix-
ture (2:1) of exo-11a and endo-11b alcohols (Scheme 2).
The major alcohol 11a was deoxygenated following the
Barton protocol7 and the resulting tricyclic tetra-
substituted olefin 12 on catalytic ruthenium oxidation
afforded the 5,8-fused cis-bicyclic dione 135 (Scheme 2).
Wittig olefination of cis-bicyclic dione 13 proceeded
regioselectively at the carbonyl group distant from the
ring junction and the gem-dimethyl group to furnish
keto-olefin 14.6 Isomerisation of the exocyclic double
bond to the desired endocyclic position in 14 proved to
be difficult due to unwanted transannular cyclisations.8
Consequently, the carbonyl group in 14 was reduced
and the resulting hydroxyl compound was protected as
a TMS–ether to give 15. Rhodium-mediated olefin iso-
merisation in 15 led to a mixture of 16a and 16b (4:1)
which could be readily separated. TMS–ether deprotec-
tion of the required isomer 16a and PDC-oxidation
yielded keto-olefin 176 (Scheme 3). Finally, Wittig olefi-
nation of 17 furnished 3, corresponding to the ‘assigned
structure’ of the natural product1c (Scheme 3).
However, the spectral data (1H and 13C NMR)6 of
synthetic 3 was distinctly different from that reported
for the natural product.1c Careful scrutiny of the spec-
tral data led us to surmise that the natural product was
the trans-isomer 4 and we undertook its synthesis.
cis-Bicyclic dione 13 on exposure to base could be
readily equilibrated with its trans-isomer 18 in which
the latter was the major product (4:1). Bicyclic trans-
dione 18, like its cis sibling 13, also underwent a facile
regioselective Wittig olefination to yield keto-olefin 19
(Scheme 4). RhCl3-mediated double-bond isomerisation
in 19 proceeded without any complications and gave a
mixture of readily separable olefinic ketones 20a and
20b (40:60) (Scheme 4). Wittig olefination on the major
compound 20b proceeded smoothly to furnish the
bicyclic hydrocarbon 4 whose spectral characteristics
(1H and 13C NMR) exactly matched those reported for
the natural product.1c,6
In short, we have accomplished the total synthesis of
the natural product (±)-asterisca-3(15),6-diene and our
synthetic efforts necessitates the revision of the earlier-
assigned structure1c of the natural product from cis-3 to
trans-4. The synthetic methodology reported here is of
general applicability and can be readily adapted for the
synthesis of other asteriscane sesquiterpenes.
Scheme 2. Reagents and conditions : (i) 580°C, FVP, 0.1 torr, quantitative; (ii) diphenyl ether, 260°C, 30 min, 80%; (iii) H2, 10%
Pd/C, EtOAc, 1 h, 95%; (iv) NaH (2 equiv.), THF, MeI (2.5 equiv.), 5–12 h, 35–50%; (v) ethanedithiol, BF3-etherate, MeOH,
0–10°C, 70%; (vi) Na–liq. NH3, THF, 30 min, 85% (2:1 exo :endo epimers); (vii) NaH, THF, imidazole, CS2, MeI, reflux, 95%;
(viii) (n-Bu)3SnH, benzene, reflux, 2 h; (ix) RuCl3, NaIO4, CCl4–CH3CN–H2O, 4 h, 70% after two steps.
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Scheme 3. Reagents and conditions : (i) MePh3P+Br−, KOtBu, benzene, 40°C, 30 min, 75%; (ii) NaBH4, MeOH, rt, 1 h, 75%; (iii)
TMS–imidazole, TBAF (cat.), THF, 15 min, 95%; (iv) RhCl3·3H2O, NaHCO3, EtOH, reflux, 1 h; (v) 10% HCl, THF, 0°C, 15 min
(1:4 mixture of 16a and 16b, respectively), 75% after two steps; (vi) PDC, 4 A MS powder, DCM, rt, 3 h, 70%; (vii) MePh3P+Br−,
KOtBu, benzene, 40°C, 30 min, 95%.
Scheme 4. Reagents and conditions : (i) KOtBu, THF, tBuOH, 20 min (4:1 equilibrium mixture of 18 and 13, respectively),
quantitative; (ii) MePh3P
+Br−, KOtBu, benzene, 40°C, 30 min, 75%; (iii) RhCl3·3H2O, NaHCO3, EtOH, , 1 h (2:3 mixture of 20a
and 20b, respectively), 90%; (iv) MePh3P+Br−, KOtBu, benzene, 40°C, 30 min, 95%.
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